Benzinga's Top #PreMarket Gainers
October 29, 2014 at 08:12 AM EDT
Cara Therapeutics (NASDAQ: CARA) shares jumped 14.45% to $9.90 in pre-market trading after the company announced positive results from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.